Zenas BioPharma, Inc. Shareholders' Equity
Zenas BioPharma, Inc. (ZBIO) had Shareholders' Equity of $247.10 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $247.10M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $335.83M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $242.14M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $196.43M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $247.10M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $335.83M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $242.14M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $196.43M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $239.63M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $284.32M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $312.46M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $359.44M 10-Q · filed 2025-11-12 |
| 2024-06-30 | -$288.78M 10-Q · filed 2025-11-12 |
| 2024-03-31 | -$252.50M 10-Q · filed 2025-11-12 |
| 2023-12-31 | -$225.72M 10-K · filed 2026-03-16 |
| 2023-09-30 | -$202.23M 10-Q · filed 2024-11-12 |
| 2023-06-30 | -$238.85M 10-Q · filed 2024-11-12 |
| 2023-03-31 | -$210.65M 10-Q · filed 2024-11-12 |
| 2022-12-31 | -$192.29M 10-K · filed 2025-03-11 |